Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study will determine the efficacy of corneal collagen crosslinking (CXL) combined with
Intacs for the treatment of keratoconus and corneal ectasia. The goal of CXL is to decrease
the progression of keratoconus, while Intacs has been shown to decrease corneal steepness in
keratoconus. This study will attempt to determine the relative efficacy of the two procedures
either performed at the same session versus CXL performed 3 months after Intacs.